Stocktoria
Shuttle Pharmaceuticals Holdings, Inc. SHPH
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-08-31
Shuttle Pharmaceuticals Holdings, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| R&D expense | $4.1M | $3.6M | $3.5M | $1.1M | $1.0M |
| Operating income | -$11.9M | -$7.7M | -$5.9M | -$2.6M | -$1.7M |
| Net income | -$11.7M | -$9.1M | -$6.6M | -$3.0M | -$1.2M |
| EPS (diluted) | $-7.16 | $-82.60 | $-3.53 | $-0.29 | — |
| Operating cash flow | -$9.5M | -$7.3M | -$5.6M | -$2.7M | -$300,336 |
| Free cash flow | — | — | -$5.6M | — | — |
| Cash & equivalents | $334,005 | $1.9M | $2.6M | $8.4M | $504,749 |
| Total assets | $10.5M | $2.5M | $6.0M | $8.7M | $651,641 |
| Total liabilities | $8.2M | $1.8M | $1.9M | $975,676 | $2.3M |
| Shareholders' equity | $2.3M | $709,152 | $4.1M | $7.7M | -$1.6M |
Source: SEC EDGAR filings · CIK 0001757499 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.